COEP - Coeptis Therapeutics Holdings, Inc.
8.27
-0.050 -0.605%
Share volume: 28,098
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$8.32
-0.05
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 08-16-2024 | 03-25-2024 | 08-16-2024 | 11-13-2024 | 08-16-2024 | 08-16-2024 | 11-13-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 6.005 M | 2.965 M | 7.146 M | 4.619 M | 2.227 M | 1.502 M | 1.416 M | 1.082 M | |
| Selling general and admin | 5.890 M | 2.499 M | 2.073 M | 3.606 M | 1.450 M | 1.104 M | 604.377 K | 737.964 K | |
| Research and development | 115.329 K | 466.629 K | 5.073 M | 1.013 M | 777.069 K | 398.817 K | 811.784 K | 343.878 K | |
| Total expenses | 6.539 M | 3.685 M | 7.901 M | 3.346 M | 2.922 M | 2.828 M | 2.142 M | 2.162 M | |
| -43.65% | 114.42% | -57.65% | -12.66% | -3.23% | -24.27% | 0.95% | |||
| Operating income | -6.539 M | -3.685 M | -7.901 M | -3.346 M | -2.922 M | -2.828 M | -2.142 M | -2.162 M | |
| Ebit | -7.926 M | -3.160 M | -6.331 M | -3.722 M | -2.801 M | -2.969 M | -1.778 M | -2.733 M | |
| Pretax income | -7.958 M | -3.203 M | -6.350 M | -3.756 M | -3.001 M | -3.035 M | -1.829 M | -3.012 M | |
| -59.76% | 98.29% | -40.86% | -20.08% | 1.13% | -39.75% | 64.68% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.958 M | -3.203 M | -6.350 M | -3.756 M | -3.001 M | -3.035 M | -1.829 M | -3.012 M | |
| 59.76% | -98.29% | 40.86% | 20.08% | -1.13% | 39.75% | -64.68% |
